News & Updates
Filter by Specialty:
Concurrent DOAC, tamoxifen use poses no elevated bleeding risk
05 Jul 2022
In breast cancer patients receiving direct oral anticoagulants (DOACs), tamoxifen is safe to use and does not increase the risk of haemorrhage as compared with concurrent use of an aromatase inhibitor (AI), a study has found.
Concurrent DOAC, tamoxifen use poses no elevated bleeding risk
05 Jul 2022
TNFi use carries only modest increase in psoriasis risk
04 Jul 2022
byJairia Dela Cruz
The use of tumour necrosis factor-α inhibitor (TNFi) for inflammatory bowel disease (IBD) or rheumatoid arthritis (RA) raises the risk of developing psoriasis by twofold as compared with conventional therapy, although the absolute risk remains modest, as reported in a study.
TNFi use carries only modest increase in psoriasis risk
04 Jul 2022
Statins reduce death, mechanical ventilation use in hospitalized COVID-19 patients
04 Jul 2022
byStephen Padilla
Hospitalized patients with COVID-19 who are treated with statins are less likely to undergo invasive mechanical ventilation or die, according to the results of a multicentre study in the US.
